Actively Recruiting
Strategic Targeting for Optimal Prevention of Cancer
Led by ClinLogic LLC · Updated on 2026-03-19
120000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
C
ClinLogic LLC
Lead Sponsor
M
MDGlobal
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are observing individuals aged 65 years or older who have undergone hereditary cancer genomic testing to understand how this testing can help assess genetic cancer risk and guide doctors in preventive care. The study focuses on hereditary cancer diagnostics to potentially enable early detection and treatment. It collects data related to patients' medical history, demographics, physician recommendations, and genetic test results for certain genes linked to hereditary cancer risks. The study does not involve new treatments but collects data from patients who have already had hereditary cancer genomic tests ordered by their physicians for medical reasons. The genes tested may vary over time as new knowledge emerges. Data collection occurs retrospectively over a period of up to 150 days, primarily through one survey form, capturing information related to genetic tests and physician treatment recommendations. Participants provide consent for their data to be included, and the study records information such as medical history, demographic details, and physician specialty. Researchers analyze these data to evaluate the clinical utility of genetic testing for cancer prevention and early detection. An interim analysis will help determine if the number of participants or data collection duration should be adjusted. The overall observation period spans approximately 120 days.
CONDITIONS
Brief Title
Strategic Targeting for Optimal Prevention of Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged 65 years or older
- Have met medical necessity for hereditary cancer genomic testing and allowed the physician to order the test
- Hereditary cancer diagnostic test ordered by a physician related to individual care
- Study subject has or had cancer
- Study subject has at least one family member with current or past cancer
You will not qualify if you...
- Currently hospitalized or incarcerated
- Unable to provide an accurate history due to mental incapacity
- Currently abusing illicit and/or prescription drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Up to 120 days
Participants undergo hereditary cancer genomic testing based on medical necessity to assess their genetic cancer risk profile.
1 visit for buccal swab collection
Duration - Up to 150 days
Participants' data is collected retrospectively during an observation period to evaluate clinical benefits and physician recommendations related to hereditary cancer genomic diagnostics.
1 case report form survey completion
Trial Site Locations
Total: 1 location
1
Sunbeam Clinical
Prosper, Texas, United States, 75078
Actively Recruiting
Research Team
C
C David, MBA
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here